Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$511K Sell
4,795
-47,191
-91% -$5.71M ﹤0.01% 1670
2026
Q1
$8.5M Buy
+51,986
New +$7.99M 0.05% 439
2025
Q4
Sell
-50,000
Closed -$7.2M 1442
2025
Q3
$7.2M Buy
+50,000
New +$6.13M 0.07% 366
2024
Q3
Sell
-3,825
Closed -$256K 1425
2024
Q2
$256K Buy
+3,825
New +$148K ﹤0.01% 1242

Other funds holding INSM

Empowered Funds's INSM Position: Q2 2026 in Review

Empowered Funds reduced its Insmed (INSM) stake by 91% in Q2 2026, selling an estimated $5.71M and leaving 4,795 shares worth $511K. The position accounts for ﹤0.01% of the portfolio, ranked #1670.

Empowered Funds first reported a position in INSM in Q2 2024 and has held it in 4 quarters since. The position peaked at $8.5M in Q1 2026. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Empowered Funds held 4,795 shares of Insmed worth $511K as of Q2 2026.
  • Empowered Funds sold 47,191 Insmed shares in Q2 2026, an estimated $5.71M.
  • Insmed made up ﹤0.01% of Empowered Funds's portfolio in Q2 2026, its #1670 holding.
  • Empowered Funds first reported a position in Insmed in Q2 2024 and has held it in 4 quarters since.
  • Empowered Funds's Insmed position peaked at $8.5M in Q1 2026.
  • 666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.